Universal-Beteiligungs- und Servicegesellschaft
SPRY icon

Universal-Beteiligungs- und Servicegesellschaft’s ARS Pharmaceuticals SPRY Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-101,679
Closed -$1.77M – 2157
2025
Q2 		$1.77M Buy
+101,679
New +$1.47M ﹤0.01% 1287

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's SPRY Position: Q3 2025 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of ARS Pharmaceuticals (SPRY) in Q3 2025, closing a stake of 101,679 shares — an estimated $1.77M sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in SPRY in Q2 2025 and held it in 1 quarter. The position peaked at $1.77M in Q2 2025. 188 funds tracked by Wall St. Rank hold SPRY as of Q3 2025.

  • Universal-Beteiligungs- und Servicegesellschaft reported no remaining ARS Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Universal-Beteiligungs- und Servicegesellschaft sold 101,679 ARS Pharmaceuticals shares in Q3 2025, an estimated $1.77M.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in ARS Pharmaceuticals in Q2 2025 and held it in 1 quarter.
  • Universal-Beteiligungs- und Servicegesellschaft's ARS Pharmaceuticals position peaked at $1.77M in Q2 2025.
  • 188 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q3 2025.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q3 2025, filed 30 Oct 2025.